和邦生物
(603077)
| 流通市值：203.12亿 | | | 总市值：203.12亿 |
| 流通股本：88.31亿 | | | 总股本：88.31亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 6,821,397,689.82 | 6,863,772,712.09 | 7,120,398,954.88 | 6,999,422,872.19 |
| 应收票据及应收账款 | 1,058,656,332.41 | 908,391,194.74 | 880,412,271.8 | 809,763,164.93 |
| 应收账款 | 1,058,656,332.41 | 908,391,194.74 | 880,412,271.8 | 809,763,164.93 |
| 应收款项融资 | 654,758,043.28 | 797,995,878.44 | 745,485,499.12 | 1,211,259,933.57 |
| 预付款项 | 231,340,644.18 | 154,643,389.18 | 193,893,890.22 | 205,432,194.96 |
| 其他应收款合计 | 52,227,676.75 | 46,097,928.05 | 42,142,152.46 | 30,071,895.93 |
| 其中:应收利息 | 664,841.97 | - | - | - |
| 存货 | 4,059,944,815.9 | 4,241,183,693.94 | 4,665,159,566.53 | 4,544,934,762.69 |
| 合同资产 | 41,792,864.05 | 36,236,841.59 | 39,775,621.45 | 21,823,366.6 |
| 其他流动资产 | 154,217,850.48 | 145,298,982.74 | 188,208,323.04 | 180,561,265.76 |
| 流动资产合计 | 13,074,335,916.87 | 13,193,620,620.77 | 13,875,476,279.5 | 14,003,269,456.63 |
| 非流动资产: | | | | |
| 长期应收款 | 126,801,802.96 | - | - | - |
| 长期股权投资 | 111,281,486.73 | 79,196,959.92 | 75,614,059.3 | 51,069,620.54 |
| 其他权益工具投资 | 300,910,882.76 | 274,987,103.89 | 359,235,510.07 | 341,106,630.13 |
| 其他非流动金融资产 | 465,278,185.83 | 465,278,185.83 | 465,278,185.83 | 465,278,185.83 |
| 固定资产 | 7,320,764,473.17 | 7,539,585,448.09 | 7,148,695,205.64 | 7,567,419,056.88 |
| 在建工程 | 2,557,528,406.01 | 2,439,455,331.29 | 2,784,181,094.54 | 2,354,469,430.77 |
| 使用权资产 | 26,008,229.42 | 28,379,404.23 | 27,965,691.69 | 30,023,932.51 |
| 无形资产 | 2,667,283,619.46 | 2,638,085,336.9 | 2,648,232,196 | 2,388,894,110.44 |
| 开发支出 | 219,887,957.62 | 201,674,441.11 | 186,136,501.1 | 173,254,914.06 |
| 商誉 | 1,838,405,543.83 | 1,838,405,543.83 | 1,838,405,543.83 | 1,838,405,543.83 |
| 长期待摊费用 | 932,075.51 | 1,030,188.71 | 1,128,301.91 | 1,226,415.11 |
| 递延所得税资产 | 135,416,687.1 | 140,832,316.52 | 127,989,543.43 | 127,226,004.13 |
| 其他非流动资产 | 449,157,313.99 | 382,787,346.87 | 306,611,137.21 | 308,091,239.02 |
| 非流动资产合计 | 16,219,656,664.39 | 16,029,697,607.19 | 15,969,472,970.55 | 15,646,465,083.25 |
| 资产总计 | 29,293,992,581.26 | 29,223,318,227.96 | 29,844,949,250.05 | 29,649,734,539.88 |
| 流动负债: | | | | |
| 短期借款 | 2,551,846,935.61 | 2,341,044,054.32 | 2,517,829,345.58 | 2,353,237,189.55 |
| 应付票据及应付账款 | 983,530,792.19 | 1,225,226,487.07 | 1,543,200,932.55 | 2,107,642,884.06 |
| 其中：应付票据 | - | - | 95,627,507.68 | 669,343,934.47 |
| 应付账款 | 983,530,792.19 | 1,225,226,487.07 | 1,447,573,424.87 | 1,438,298,949.59 |
| 合同负债 | 149,419,399.88 | 88,478,264.03 | 115,662,092.46 | 45,100,553.29 |
| 应付职工薪酬 | 45,393,124.11 | 46,384,459.09 | 46,632,058.53 | 57,939,446.54 |
| 应交税费 | 61,783,461 | 62,789,281.46 | 55,435,464.02 | 34,933,171.55 |
| 其他应付款合计 | 25,771,453.61 | 28,363,452.32 | 31,171,419.87 | 19,225,866.29 |
| 一年内到期的非流动负债 | 434,594,174.61 | 468,129,681.24 | 600,835,022.89 | 751,978,245.32 |
| 其他流动负债 | 12,271,008.86 | 6,335,230.55 | 12,297,518.93 | 4,451,202.01 |
| 流动负债合计 | 4,264,610,349.87 | 4,266,750,910.08 | 4,923,063,854.83 | 5,374,508,558.61 |
| 非流动负债: | | | | |
| 长期借款 | 1,670,999,448.35 | 1,650,801,761.21 | 1,664,892,188.97 | 766,438,037.89 |
| 应付债券 | 4,261,462,536.39 | 4,230,823,804.03 | 4,200,345,384.44 | 4,169,656,332.92 |
| 租赁负债 | 13,893,934.57 | 15,833,665.67 | 13,139,663.93 | 14,524,544.67 |
| 递延收益 | 127,361,577.64 | 128,296,330.15 | 129,231,082.66 | 130,165,835.17 |
| 递延所得税负债 | 190,150,045.19 | 190,210,204.99 | 188,917,155.19 | 187,923,024.98 |
| 非流动负债合计 | 6,263,867,542.14 | 6,215,965,766.05 | 6,196,525,475.19 | 5,268,707,775.63 |
| 负债合计 | 10,528,477,892.01 | 10,482,716,676.13 | 11,119,589,330.02 | 10,643,216,334.24 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 8,831,391,228 | 8,831,364,728 | 8,831,250,228 | 8,831,250,228 |
| 其他权益工具 | 364,198,769.49 | 364,202,965.95 | 364,221,097.83 | 364,221,097.83 |
| 资本公积 | 948,645,783.19 | 948,647,938.63 | 944,532,765.14 | 1,034,783,513.95 |
| 减:库存股 | 1,789,756,980.29 | 1,789,756,980.29 | 1,789,756,980.29 | 1,696,878,905.84 |
| 其他综合收益 | -27,505,698.84 | -16,994,897.99 | 3,414,605.59 | -8,853,745.01 |
| 专项储备 | 19,744,977.82 | 20,124,704.59 | 24,726,214.52 | 23,787,328.03 |
| 盈余公积 | 600,901,424.23 | 600,828,045.44 | 600,422,803.2 | 600,422,803.2 |
| 未分配利润 | 9,575,076,238.71 | 9,533,078,815.23 | 9,490,177,424.66 | 9,477,660,111.71 |
| 归属于母公司股东权益合计 | 18,522,695,742.31 | 18,491,495,319.56 | 18,468,988,158.65 | 18,626,392,431.87 |
| 少数股东权益 | 242,818,946.94 | 249,106,232.27 | 256,371,761.38 | 380,125,773.77 |
| 股东权益合计 | 18,765,514,689.25 | 18,740,601,551.83 | 18,725,359,920.03 | 19,006,518,205.64 |
| 负债和股东权益合计 | 29,293,992,581.26 | 29,223,318,227.96 | 29,844,949,250.05 | 29,649,734,539.88 |
| 公告日期 | 2025-10-29 | 2025-08-20 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |